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1. Introduction 
This manuscript presents methods used to test, and resulting evidence to support the 
hypothesis that specialized transcription factor binding sites coordinate the expression of 
DNA repair genes. Building on the seminal work of the Elnitski laboratory (Yang et al. 
2007), which identified the most complete set of human transcripts under the control of 
bidirectional promoters and identified the first putative regulatory networks that make use 
of the bidirectional promoter structure, the authors present additional details of these 
regulatory networks. 
Much of the work regarding the regulation of DNA repair proteins is aimed at the level of 
protein-protein interactions and post-translational processing events (Hurley et al. 2007, 
Jensen et al. 2011, Shibata et al. 2010). However, transcriptional activation of DNA repair 
genes is likely to utilize shared factors, especially in cases of induced activation, which have 
not been thoroughly evaluated. Yang, Koehly and Elnitski reported the discovery and 
characterization of 5,653 bidirectional promoters in the human genome (Yang et al. 2007). 
Prior to that date, bidirectional promoters were annotated only for protein-coding genes, 
and only 1,352 examples had been reported in the human genome. The work of Yang et al. 
included evidence from all noncoding-RNA genes, as well. Each bidirectional promoter 
regulates the expression of two genes, oriented in opposite directions with transcription 
start sites within 1000 bp of one another. The authors developed a novel approach to map all 
bidirectional promoters by analyzing the public expressed-sequence-tag (EST) data. The 
prevalence of this promoter structure led the authors to explore the hypothesis that it plays 
a role in regulation of certain classes of genes. They discovered that many more DNA repair 
genes have bidirectional promoters than previously reported and that many genes with 
somatic mutations in cancer have bidirectional promoters. The relevance of DNA repair 
genes to cancers (Kinsella et al. 2009, Liang et al. 2009, Smith et al. 2010, Kelley et al. 2008, Li 
et al. 2009, Bellizii et al. 2009, Naccarati et al. 2007, Berwick et al. 2000)) and the association 
of bidirectional promoters with DNA repair genes suggested that bidirectional promoters 
might indicate a higher-order type of regulatory structure that could be detected through 
common features at the DNA sequence level. If true, these features should discriminate 
bidirectional promoters and unidirectional promoters of genes with DNA repair functions. 
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Thus, this chapter presents additional evidence of these regulatory networks. Specifically, 
this chapter provides evidence that there are distinct regulatory signatures for (1) genes 
involved in certain types of cancers, (2) bidirectional versus unidirectional promoters and (3) 
specific DNA repair pathways.  The authors have identified transcription factor binding 
sites in bidirectional promoters of genes implicated in breast and ovarian (B/O) cancers. 
Additionally, they have discovered novel transcription factor binding sites that may serve as 
regulatory elements to distinguish DNA repair genes with bidirectional promoters from 
DNA repair genes with unidirectional promoters. Applications of this work extend to a 
collection of novel transcription factor binding sites shared among genes acting as 
checkpoint factors of DNA repair pathways. These findings have important implications – 
as evidence of novel regulatory mechanisms, and new insights into cancer biology (i.e., 
genomic elements relevant to transcriptional regulation) are gained.   
2. Regulatory features of genes implicated in breast and ovarian cancers 
This section provides evidence to support the hypothesis that there are distinct regulatory 
control systems among bidirectional and unidirectional promoters. Additionally, this 
section presents transcription factor binding sites discovered in bidirectional promoters of 
genes implicated in breast and ovarian cancers.  
As reported in Yang et al. 2007, we identified transcription factor binding sites for known 
factors in genes implicated in B/O cancers. The enrichment of bidirectional promoters in 
several cancer genes, and in additional genes having functions in DNA repair, suggests 
common mechanisms of regulation.  We used expression clustering and enrichment of genes 
with bidirectional promoters to group the cancer genes into expression groups from the full 
genome to address features common among the clusters that might indicate the presence of 
regulatory networks. The cancer-related genes that were identified and studied are listed 
below, along with their descriptions from GeneCards (Safran et al. 2010). The Elnitski group 
was the first to report that this set of genes has bidirectional promoters. 
All genes were assessed for the top most related gene expression profiles in the genome 
using the gene sorter tool at the UCSC Genome Browser and expression data from the 
Novartis GNF Atlas2 (containing expression profiles for 96 tissues). Each cluster was then 
compared to all the others to identify intersection points (by gene names) among the lists of 
co-expressed genes. Using a process of multidimensional scaling, the gene lists were 
compared and a putative regulatory network was generated (Figure 1). The MLH1 gene 
appeared in several co-expression clusters and therefore occupied a central location with 
connections to 7 other genes (BARD1, FANCA, BRCA1, CHK2, BRCA2, TP53 and FANCF). 
Two additional genes co-occupied the central position with MLH1. COMMD3 (an 
uncharacterized protein) and ITGB3BP, a regulator of apoptosis in breast cancer cells.  
2.1 Network visualization  
The bidirectional promoters that are associated with the breast and ovarian cancer genes 
were considered an affiliation network or a bipartite graph. In this example nodes represent 
the genes in the co-expression clusters and edges connect the genes appearing in more than 
one list. The higher the number of appearances of any gene from the ten co-expression lists, 
the more central its position in the network. Geodesic distances between genes were 
computed (e.g. length of the shortest path between genes through promoters, and the 
geodesic distance matrix was scaled using a metric multidimensional scaling (MDS)  
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Gene Description from GeneCards (Safran 2010) 
BARD1  This gene encodes a protein which interacts with the N-terminal region of 
BRCA1.  
BRCA1 This gene encodes a nuclear phosphoprotein that plays a role in 
maintaining genomic stability, and it also acts as a tumor suppressor. 
BRCA2 Inherited mutations in BRCA1 and this gene, BRCA2, confer increased 
lifetime risk of developing breast or ovarian cancer. 
CHK2 In response to DNA damage and replication blocks, cell cycle progression 
is halted through the control of critical cell cycle regulators. The protein 
encoded by this gene is a cell cycle checkpoint regulator and putative 
tumor suppressor. 
ERBB2  This gene encodes a member of the epidermal growth factor (EGF) 
receptor family of receptor tyrosine kinases.  
TP53 This gene encodes tumor protein p53, which responds to diverse cellular 
stresses to regulate target genes that induce cell cycle arrest, apoptosis, 
senescence, DNA repair, or changes in metabolism. 
FANCA DNA repair protein that may operate in a post-replication repair or a cell 
cycle checkpoint function. May be involved in inter-strand DNA cross-
link repair and in the maintenance of normal chromosome stability. 
FANCB  DNA repair protein required for FANCD2 ubiquitination.  
FANCD2 Required for maintenance of chromosomal stability. Promotes accurate 
and efficient pairing of homologs during meiosis. Involved in the repair of 
DNA double-strand breaks, both by homologous recombination and 
single-strand annealing. May participate in S phase and G2 phase 
checkpoint activation upon DNA damage. Promotes BRCA2/FANCD1 
loading onto damaged chromatin. 
FANCF DNA repair protein that may operate in a postreplication repair or a cell 
cycle checkpoint function. May be implicated in interstrand DNA cross-
link repair and in the maintenance of normal chromosome stability. 
Table 1. The B/O cancer-related genes that were studied. 
algorithm (in UCINET 6; Borgatti et al., 2002). The distance between the 10 B/O cancer 
genes represents their similarity based on the number of shared genes found in the co-
expression clusters. Genes in the center of the network were present in the largest number of 
gene clusters, seven out of 10, indicating that co-expression clusters intersect through 
common regulatory nodes. 
2.2 Transcription factor binding site analysis 
A systematic search of transcription factor binding sites in the list of bidirectional promoters 
was used to assess regulatory connections at the DNA level, and revealed several in common 
(using a motif finding algorithm we searched for the motifs reported in (Xie et al. 2005)). 
Notably, identical ELK1 binding sites were located at the same distance from ERBB2, FANCD2, 
and BRCA2 transcription start sites (Yang et al. 2007). ETS factor binding sites were present as 
a trio with SP1 and PAX4/RXR binding sites in the majority of the promoters. The transcription 
factors for which binding motifs were found in all of the promoters along with their 
descriptions from GeneCards (Safran et al. 2010) are reported in Table 2. 
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Fig. 1. Co-expression clustering analysis of 10 DNA repair genes finds intersecting nodes. 
 
Transcription 
Factor 
Description from GeneCards 
Sp1 Transcription factor that can activate or repress transcription in 
response to physiological and pathological stimuli. Regulates the 
expression of a large number of genes involved in a variety of 
processes such as cell growth, apoptosis, differentiation and immune 
responses. May have a role in modulating the cellular response to 
DNA damage. 
NFAT The nuclear factor of activated T-cells family of transcription factors. 
EGR-1 The protein encoded by this gene belongs to the EGR family of 
C2H2-type zinc-finger proteins. It is a nuclear protein and functions 
as a transcriptional regulator. Studies suggest this is a cancer 
suppressor gene. 
PAX4  This gene is a member of the paired box (PAX) family of 
transcription factors. These genes play critical roles during fetal 
development and cancer growth.  
ELK1  ELK1 is a member of ETS oncogene family. The protein encoded by 
this gene is a nuclear target for the ras-raf-MAPK signaling cascade.  
Table 2. Transcription factor binding sites in the promoters of the B/O cancer genes. 
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3. Unbiased assessment of transcription factor binding sites in two 
subgroups of genes from DNA repair pathways 
The research reported in (Yang et al. 2007) provides strong evidence that a unique set of 
regulatory proteins control genes that contain bidirectional promoters by comparing co-
expression clusters of genes enriched for bidirectional promoters versus those depleted 
for bidirectional promoters. This section reports on a study that identified transcription 
factor binding sites that are specific to genes in DNA repair pathways (Lichtenberg et al. 
2009). The promoters of genes from the DNA repair pathways were partitioned into two 
groups, those that are bidirectional (32 promoters) and those that are unidirectional (42 
promoters).  
3.1 Assessment of individual sites  
Each group of promoters was analyzed to discover putative transcription factor binding 
sites. The analysis was performed with WordSeeker motif discovery software 
(Lichtenberg et al. 2010), which employs high performance supercomputer-based 
algorithms to perform motif enumeration and to construct Markov models. Our analysis 
revealed that the average nucleotide G+C content of the bidirectional promoters was 
slightly higher than the unidirectional promoters, 59.87% versus 50.84%, respectively. 
These differences were rigorously controlled by the use of the Markov model, which 
examines background frequencies of each nucleotide in the collection of sequences. 
Unique sets of binding sites were identified for each group, some of which represent 
novel binding sites.  
A statistical analysis of the promoters of the DNA repair genes revealed a number of 
significant DNA binding site motifs. Some of the discovered motifs correspond to 
recognition sequences of known proteins. These are listed in Table 3, along with their p-
values and the corresponding transcription factors known to bind to the motifs (as 
determined by the TRANSFAC database (Wingender et al. 2000) and the JASPAR database 
(Bryne et al. 2008)). In addition, novel motifs, representing uncharacterized transcription 
factor binding sites, were discovered in the bidirectional and unidirectional promoters from 
DNA repair pathway genes (see Table 4 for the motifs and their p-values).  
 
Motif 
(bidirectional 
promoters) 
p-Value 
Transcription
Factor 
Motif 
(unidirectional
promoters) 
p-Value 
Transcription 
Factor 
AGGGCCGT 0.04142 MYB ACCCGCCT 0.00656 SP1 
CAGGGGCC 0.02841 V$WT1_Q6 AGGAAACA 0.03295 NFAT 
CGTGGGGG 0.04701 E2F ATTAAAAT 0.05372 OCT1 
GGCCCGCC 0.06682 SP1 CGGAAACC 0.04210 AREB6 
TCCCGGCT 0.05408 ELK1 GCAGGGCG 0.07134 PF0096 
TCCCGGGA 0.06861 STAT5A GGGGAGTA 0.03321 FOXC1 
TCGCGCCA 0.01539 PF0112 GGGGCTGC 0.06212 LRF 
TCTGAGGA 0.01350 TFIIA TGGGCGGA 0.06334 GC 
Table 3. Enriched motifs matching characterized transcription factor binding sites 
discovered in the bidirectional promoters (columns 1 and 2) and in the unidirectional 
promoters (columns 3 and 4). 
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Motif (bidirectional 
promoters) 
P-Value Motif 
(unidirectional 
promoters) 
P-Value 
ACTCCAGC 0.06212 AGCCGGCT 0.05007 
AGAAAAGA 0.02756 ATTCCCAG 0.05599 
AGGGAGGG 0.07159 CCTCTTTA 0.03381 
CAGCAGCC 0.10540 CGCCCCTT 0.11386 
CGACTCCG 0.02756 CGGCGGCG 0.04742 
CGCGGCCG 0.03377 CTCCCGCT 0.05998 
CGGGCCGA 0.06548 CTTCTTTC 0.03773 
GCCCCTCC 0.07021 GCGCCGCG 0.09760 
GCCGGCGA 0.03662 GGGCGCCC 0.08390 
GGCAGGGA 0.10334 GTGCGTTT 0.06286 
GGGCCAGG 0.09632 TCCGCCGG 0.05794 
GGGGCCGG 0.05265 TCTCCCCT 0.07881 
TCTGGGAT 0.01466 TCTTCTTC 0.04649 
TGAAGCCA 0.05699 TGCGCCGA 0.04148 
TGCCCGCG 0.08277 TTGGTCTC 0.08543 
TGCGGAAT 0.02132 TTTCTCCA 0.06840 
TGCTGAGA 0.03377 TTTTTTGA 0.04742 
Table 4. Uncharacterized motifs discovered in the promoters of DNA repair genes. Words 
are ordered alphabetically. 
3.2 Assessment of paired binding sites  
To identify putative regulatory modules (co-acting regulatory elements), we identified 
statistically overrepresented pairs of DNA motifs in each set of promoters. Motif pairs are 
shown in Table 5. The motif pair scores are computed as the product of (1) the number 
sequences, S, in which the pair occurs and (2) the natural log of the ratio of S and the 
expected value of S, Es; i.e., the score is S·ln(S/Es). The genomic signatures (significant DNA 
motifs and motif pairs) of the bidirectional promoters were virtually non-overlapping with 
the signatures of unidirectional promoters. This provides strong support for the hypothesis 
that the regulatory mechanisms of bidirectional promoters are unique. Additionally, this 
work contributes a significant enhancement to the available knowledge about 
transcriptional regulation of genes involved in DNA repair pathways, and implicates the 
presence of a regulatory network. 
4. Unbiased assessment of transcription factor binding sites of checkpoint 
factor genes from DNA repair pathways 
We have performed a focused, detailed characterization of the checkpoint factors in DNA 
repair pathways (Elnitski et al. 2010). The checkpoint factors (Kanehisa et al. 2008, Wood 
2005, Helleday et al. 2008) are activated upon detection of DNA damage, resulting in halting 
the cell cycle so that subsequent DNA repair pathways can mend the damage. In addition to 
examining the most recognized promoter in each gene (the 5’ end of the full-length 
transcription unit), we assessed alternative start sites for each checkpoint factor gene as 
independent regulatory units, to discover putative transcription factor binding sites. In this  
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Co-Occurring Motif Pair 
(Bidirectional Promoters) 
Score 
Co-Occurring Motif Pair 
(Unidirectional Promoters) 
Score 
TCTGAGGA TCGCGCCA 12.1158 GTTCATTC TCCGCCGG 11.2184 
ACTCCAGC TCGCGCCA 11.8387 CTGTGTGC TGCGCCGA 11.1966 
GCCCAGCC TCCGCCGC 11.1827 TGACGCGA CTCCCGCT 10.9997 
GCCCAGCC CGGAGCGC 10.8711 AGCCGGCT GGGGAGTA 10.0590 
TGCCCGCG TCCCGGGA 10.7404 ATTGCAGG ATTCTCTC 9.5459 
GGCAGGGA GGGCCAGG 9.8609 GGGGAGTA AGGAAACA 9.3177 
TCCCGGGA TCGCGCCA 9.8112 CTGGGAGC GTTCATTC 9.0337 
AGCCTGTC TCCCGGGA 9.7646 CCTTCCGA CTGGGAGC 8.8439 
GGAGGCTG TCGCGCCA 9.7250 TGGGCGGA ACCCGCCT 8.7895 
TCCGCCGC GCCCCTCC 9.6830 TTTCTCCA CGGAAACC 8.6446 
AGAAAAGA TCGCGCCA 9.4042 CCCCCGCG ACCCGCCT 8.5339 
GCCCAGCC GCCCCTCC 9.2808 TCCGCCGG GGGGCTGC 7.7522 
TGCCAAAA GCCGGCGA 9.2604 AGCTGGCT CCAGGCTG 7.7192 
CAGCAGCC TGCGGAAT 9.1297 TTGGTCTC AGGAAACA 7.6068 
AGGGCCGT TCCCGGCT 9.1249 CTGGGAGC TCCGCCGG 7.3021 
Table 5. Putative transcription factor binding modules discovered in promoters of DNA 
repair genes. 
section we report the DNA motifs that were discovered, along with several clusters of 
related genes and promoters. We hypothesize that these similar components implicate 
regulatory networks responsible for co-regulation of the checkpoint factor genes. 
We studied fourteen checkpoint factor genes, which are listed in Table 6. The number of 
alternative promoters per gene, shown in parentheses, varied for each gene. Because most of 
the genes have alternative promoters, we analyzed a total of thirty promoters. The complete 
set of alternative promotes is shown in Table 7. Alternative promoters were identified using 
annotations of genes in the UCSC Human Genome Browser. Transcription start sites of 
transcript isoforms served as the coordinates around which 900 bp upstream and 100 bp 
downstream were defined as the putative promoter region. Alternative promoters with 
significant overlap were truncated or removed from the analysis. DNA sequences were 
obtained for the forward and reverse strands of the genome to ensure coverage of words 
that might have biased nucleotide content and be subject to omission during the Markov 
model analysis stage. 
 
Gene Description from GeneCards (Safran 2010) 
ATM (5) The protein encoded by this gene (ataxia telangiectasia mutated) 
belongs to the PI3/PI4-kinase family. This protein functions as a 
regulator of a wide variety of downstream proteins, including p53, 
BRCA1, CHK2, RAD17, RAD9, and NBS1. This protein and the closely 
related kinase ATR are thought to be master controllers of cell cycle 
checkpoint signaling pathways, required for cell response to DNA 
damage and for genome stability.  
ATR (2)  The protein encoded by this gene (ataxia telangiectasia and Rad3 
related) belongs the PI3/PI4-kinase family, and is most closely 
related to ATM. Both proteins share similarity with 
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Schizosaccharomyces pombe rad3, a cell cycle checkpoint gene 
required for cell cycle arrest and DNA damage repair in response to 
DNA damage. This kinase has been shown to phosphorylate CHK1, 
RAD17, and RAD9 and BRCA1. Transcript variants utilizing 
alternative polyA sites exist. 
ATRIP (1) The product of this gene (ATR interacting protein) is an essential 
component of the DNA damage checkpoint, and binds to single-
stranded DNA coated with replication protein A that accumulates at 
sites of DNA damage. The encoded protein interacts with the ataxia 
telangiectasia and Rad3 related protein, a checkpoint kinase, 
resulting in accumulation of the kinase at intranuclear foci induced 
by DNA damage. Multiple transcript variants encoding different 
isoforms have been found for this gene. 
CHEK1 (3)  Required for checkpoint mediated cell cycle arrest in response to 
DNA damage or the presence of unreplicated DNA. May also 
negatively regulate cell cycle progression during unperturbed cell 
cycles. Binds to and phosphorylates CDC25A, CDC25B and CDC25C. 
Binds to and phosphorylates RAD51. Binds to and phosphorylates 
TLK1. May also phosphorylate multiple sites within the C-terminus 
of TP53, which promotes activation of TP53 by acetylation and 
enhances suppression of cellular proliferation. 
CHEK2 (2) The protein encoded by this gene is a cell cycle checkpoint regulator 
and putative tumor suppressor. It contains a forkhead-associated 
protein interaction domain essential for activation in response to 
DNA damage and is rapidly phosphorylated in response to 
replication blocks and DNA damage. This protein interacts with and 
phosphorylates BRCA1, allowing BRCA1 to restore survival after 
DNA damage. Three transcript variants encoding different isoforms 
have been found for this gene. 
CLK2 (2) This gene encodes a member of the CLK family of dual specificity 
protein kinases. CLK family members have been shown to interact 
with, and phosphorylate, serine- and arginine-rich (SR) proteins of 
the spliceosomal complex, which is a part of the regulatory 
mechanism that enables the SR proteins to control RNA splicing.  
HUS1 (1) The protein encoded by this gene is a component of an evolutionarily 
conserved, genotoxin-activated checkpoint complex that is involved 
in the cell cycle arrest in response to DNA damage. This protein 
forms a heterotrimeric complex with checkpoint proteins RAD9 and 
RAD1. DNA damage induced chromatin binding has been shown to 
depend on the activation of the checkpoint kinase ATM, and is 
thought to be an early checkpoint signaling event. 
MDC1 (2) The protein encoded by this gene (mediator of DNA-damage 
checkpoint) is required to activate the intra-S phase and G2/M phase 
cell cycle checkpoints in response to DNA damage. This nuclear 
protein interacts with phosphorylated histone H2AX near sites of 
DNA double-strand breaks through its BRCT motifs, and facilitates 
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recruitment of the ATM kinase and meiotic recombination 11 protein 
complex to DNA damage foci. 
NBS1 (1) The encoded protein is a member of the MRE11/RAD50 double-
strand break repair complex which consists of 5 proteins. This gene 
product is thought to be involved in DNA double-strand break repair 
and DNA damage-induced checkpoint activation. 
P53/TP53 (3)  This gene encodes tumor protein p53, which responds to diverse 
cellular stresses to regulate target genes that induce cell cycle arrest, 
apoptosis, senescence, DNA repair, or changes in metabolism. 
PER1 (1) This gene is a member of the Period family of genes and is expressed 
in a circadian pattern in the suprachiasmatic nucleus, the primary 
circadian pacemaker in the mammalian brain. Genes in this family 
encode components of the circadian rhythms of locomotor activity, 
metabolism, and behavior. The specific function of this gene is not 
yet known. Alternative splicing has been observed in this gene; 
however, these variants have not been fully described. 
RAD1 (2) This gene encodes a component of a heterotrimeric cell cycle 
checkpoint complex, known as the 9-1-1 complex, that is activated to 
stop cell cycle progression in response to DNA damage or 
incomplete DNA replication. The 9-1-1 complex is recruited 
by RAD17 to affected sites where it may attract specialized DNA 
polymerases and other DNA repair effectors. Alternatively spliced 
transcript variants of this gene have been described. 
RAD17 (3) The protein encoded by this gene is highly similar to the gene 
product of Schizosaccharomyces pombe rad17, a cell cycle 
checkpoint gene required for cell cycle arrest and DNA damage 
repair in response to DNA damage. This protein recruits the RAD1-
RAD9-HUS1 checkpoint protein complex onto chromatin after DNA 
damage,. The phosphorylation of this protein is required for the 
DNA-damage-induced cell cycle G2 arrest, and is thought to be a 
critical early event during checkpoint signaling in DNA-damaged 
cells. Eight alternatively spliced transcript variants of this gene, 
which encode four distinct proteins, have been reported.  
RAD9A (2) This gene product is highly similar to Schizosaccharomyces pombe 
rad9, a cell cycle checkpoint protein required for cell cycle arrest and 
DNA damage repair in response to DNA damage. This protein is 
found to possess 3' to 5' exonuclease activity, which may contribute 
to its role in sensing and repairing DNA damage. It forms a 
checkpoint protein complex with RAD1 and HUS1. This complex is 
recruited by checkpoint protein RAD17 to the sites of DNA damage, 
which is thought to be important for triggering the checkpoint-
signaling cascade. Use of alternative polyA sites has been noted for 
this gene. 
Table 6. The checkpoint factors genes that were studied. The number of alternative 
promoters is shown in parentheses next to each gene name. 
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Checkpoint
Factors 
Alternative promoters (hg18 coordinates) 
ATM 
(ATM5)   chr11:107662328-107663378_+ 
(ATM5)   chr11:107662328-107663378_- 
(ATM2)   chr11:107643346-107644396_+ 
(ATM2)   chr11:107643346-107644396_- 
(ATM3)   chr11:107597768-107598818_+ 
(ATM3)   chr11:107597768-107598818_- 
(ATM4)   chr11:107671910-107672960_+ 
(ATM4)   chr11:107671910-107672960_- 
(ATM5)   chr11:107679611-107680661_+ 
(ATM5)   chr11:107679611-107680661_- 
ATR 
(ATR1)    chr3:143780308-143781358_+ 
(ATR1)    chr3:143780308-143781358_- 
(ATR2)    chr3:143671051-143672101_+ 
(ATR2)    chr3:143671051-143672101_- 
ATRIP 
chr3:48462221-48463271_+ 
chr3:48462221-48463271_- 
CHEK1 
(CHEK13) chr11:125000333-125001383_+ 
(CHEK13) chr11:125000333-125001383_- 
(CHEK12) chr11:125018185-125019235_+ 
(CHEK12) chr11:125018185-125019235_- 
(CHEK13) chr11:124999245-125000295_+ 
(CHEK13) chr11:124999245-125000295_- 
CHEK2 
(CHEK22) chr22:27467772-27468822_+ 
(CHEK22) chr22:27467772-27468822_- 
(CHEK22) chr22:27460665-27461715_+ 
(CHEK22) chr22:27460665-27461715_- 
CLK2 
(CLK22)   chr1:153509855-153510905_+ 
(CLK22)   chr1:153509855-153510905_- 
(CLK22)   chr1:153514075-153515125_+ 
(CLK22)   chr1:153514075-153515125_- 
HUS1 
chr7:47985721-47986771_+ 
chr7:47985721-47986771_- 
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MDC1 
(MDC12)  chr6:30792781-30793831_+ 
(MDC12)  chr6:30792781-30793831_- 
(MDC12)  chr6:30789060-30790110_+ 
(MDC12)  chr6:30789060-30790110_- 
NBS1 
chr8:91066025-91067075_+ 
chr8:91066025-91067075_- 
P53 (TP53) 
(TP533)   chr17:7519486-7520536_+ 
(TP533)   chr17:7519486-7520536_- 
(TP532)   chr17:7531538-7532588_+ 
(TP532)   chr17:7531538-7532588_- 
(TP533)   chr17:7520612-7521662_+ 
(TP533)   chr17:7520612-7521662_- 
PER1 
chr17:7996377-7997427_+ 
chr17:7996377-7997427_- 
RAD1 
(RAD12)   chr5:34954089-34955139_+ 
(RAD12)   chr5:34954089-34955139_- 
(RAD12)   chr5:34951438-34952488_+ 
(RAD12)   chr5:34951438-34952488_- 
RAD17 
(RAD173)  chr5:68699879-68700929_+ 
(RAD173)  chr5:68699879-68700929_- 
(RAD172)  chr5:68723716-68724766_+ 
(RAD172)  chr5:68723716-68724766_- 
(RAD173)  chr5:68701287-68702337_+ 
(RAD173)  chr5:68701287-68702337_- 
RAD9A 
(RAD9A2)  chr11:66918716-66919766_+ 
(RAD9A2)  chr11:66918716-66919766_- 
(RAD9A2)  chr11:66914998-66916048_+ 
(RAD9A2)  chr11:66914998-66916048_- 
Table 7. Alternative promoters, indicated by their genomic coordinates, of genes involved in 
cell-cycle checkpoint factor pathways. 
Statistical analysis of thirty promoters found several interesting DNA words, which predict 
DNA elements that participate in the regulation of the DNA repair checkpoint factors. The 
most significant words discovered are listed in Table 8. Words that are shared among the 
gene sets identify regulatory relationships. Reverse complement words are reported 
separately, as internal verification on the process. Words without a reverse complement 
example indicate a particular bias in the nucleotide content. 
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Word Promoters Sln(S/Es)
ACAGCCAT 
ATM2
5.41 CHEK22
CLK21
ATGGCTGT 
ATM2
5.41 CHECK22
CLK21
GCCTGGGA 
ATR1
5.40 
CHEK21
CLK22
MDC11
MDC12
RAD12
TCCCAGGC 
ATR1
5.40 
CHEK21
CLK22
MDC11
MDC12
RAD12
ACTCCCTA 
ATM3
5.29 CHEK21
RAD172
TAGGGAGT 
ATM3
5.29 CHEK21
RAD172
AGCGGCCA 
ATR1
5.24 ATR2
CHEK11
TGGCCGCT 
ATR1
5.24 ATR2
CHEK11
GAAATGAA 
ATM2
5.24 
ATM3
ATR2
CLK22
HUS1
MDC11
TTCATTTC 
ATM2
5.24 
ATM3
ATR2
CLK22
HUS1
MDC11
AATGCAGG 
RAD11
4.97 
TP531
TP532
TP533
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CCTGCATT 
RAD11 
4.97 
TP531 
TP532 
TP533 
ATCCCTGA 
ATRIP 
4.73 
CHEK13 
RAD12 
RAD171 
TCAGGGAT 
ATRIP 
4.73 
CHEK13 
RAD12 
RAD171 
GTATTTTA 
ATM4 
4.58 
CHEK12 
NBS1 
RAD171 
ATR2 
TP531 
HUS1 
RAD171 
Table 8. Top 15 enumerated DNA words, based on the S·ln(S/ES) overrepresentation score, 
and the alternative promoters, identified by subscript. 
5. Visualization and interpretation of data 
Shared words among the checkpoint factor genes suggested the presence of regulatory 
networks. We assessed the relationships by generating network depictions in the form of 
interaction networks (Figure 2) and a circos diagram (Figure 3) constructed from the 
summary data in Table 9. To derive Figure 2, a metric MDS was conducted on the affiliation 
network defined in Table 9. The resulting graph was then spring-embedded, with node 
repulsion, to facilitate visualization (Borgatti, 2002). The interaction network depicts the 
distribution of the DNA words among the genes (note that each gene appears once, 
representing all alternative promoters as a single node). Genes are denoted by blue squares 
and words are represented with red circles. Bold lines indicate multiple occurrences of a 
word. Reverse complement words are shown independently.  
The circos diagram represents the information in a closed circular space, wherein 
connections between words on one side of the diagram extend to genes on the other  
side. The putative nodes of the regulatory networks are defined by multiple edges, 
representing a characterized transcription factor or a novel DNA binding site, or a 
checkpoint factor gene.  
Some of the discovered words correspond to known binding sites for transcription factors, 
reported in the JASPAR and TRANSFAC databases of transcription factors (see Table 10). 
The relationships between the top fifteen words and the transcription factors are depicted in 
the circos diagram in Figure 4. Note that multiple binding site motifs were discovered for 
many of the transcription factors, and that several of the sites match the binding patterns of 
more than one transcription factor.  
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Table 9. The top ranked words (rows of the table), based on statistical significance (S·ln(S/ 
Es)), and the number of occurrences of each word in the promoter regions of genes 
(columns). 
 
 
Fig. 2. Model of the checkpoint regulatory network using multidimensional scaling. 
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Edge: Represents a cell value by 
using  an edge to connect row and 
column entries. The width is 
proportional to the cell value.
Inner ring: Each edge is 
colored to correspond 
with a row item; each 
edge end is colored to 
correspond with a 
column item. 
Ring 2: Represents a  
row or a column; 
width is proportional 
to sum of cell values 
in the corresponding 
row or column. Ring 3: Represents  
relative contributions 
of cells to row and 
column totals. Each 
color represents one 
cell; percentage is 
the proportion of a 
cell’s value to the 
row or column sum.
 
Fig. 3. Circos 2diagram of the top 15 words, based on statistical significance, and their 
occurrences in gene promoter regions. 
 
TFBS S·ln(S/Es) TF
ACCCCCAC 3.76 PF0091, Pax-4
ACTCCCTA 4.67 Helios A, p300
ATGGCTGT 5.42 Cap
ATTAAAGA 3.72 Pax-2
CGGAGCCC 3.95 LF-A1
CTGAAATT 3.80 STAT1, STAT6
CTTTTGAA 3.83 TCF-4
GAAAAATT 3.76 CIZ
GCACCTGC 3.68 PF0035, AP-4, cap, Lmo2 complex
GTGGCTGC 3.64 cap
TACTTTTT 3.82 FOXC, CIZ, RUSH-1alpha1
TATATTTA 3.82 FOXL1, PF0028, PF0054
TCCTTTCT 3.70 Pax-2
TTTTTATA 3.64 FOXL1
Table 10. Known transcription factor binding sites (with significance scores and corresponding 
transcription factor) discovered in the promoters of the checkpoint factors genes. 
Additional insight into the regulatory network for the checkpoint factors can be seen in 
Figure 5, which replaces the DNA binding site motifs with the names of implicated 
transcription factors for each DNA repair gene. The diagram indicates the discovery of 
specific transcription factors involved in the control of each gene and shared among 
multiple genes. Up to seven transcription factors were discovered for each gene.   
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Fig. 4. Circos diagram showing the top 15 DNA motifs found in promoters of checkpoint 
factor genes and their related transcription factors (number of occurrences are multiplied by 
100). 
6. Conclusions 
This chapter provides a summary of research into transcriptional regulatory networks 
controlling DNA repair pathways, bidirectional versus unidirectional promoters of DNA 
repair genes, and bidirectional promoters of breast and ovarian cancer genes. DNA words 
are shared among these promoters, and these words represent both known and unknown 
binding sites for transcription factors. When possible, we report the highest scoring 
assignment of transcription factor to DNA word. Our research represents a novel approach 
to identifying factors involved in transcriptional regulation of DNA repair genes. Many of 
these proteins have dual roles in transcription and DNA repair. Although many of the 
regulatory relationships are characterized at the level of protein-protein interactions, little 
research is available on the transcriptional regulatory networks that control DNA repair 
gene expression. We present evidence that regulatory networks exist among these genes, 
and support the claim that bidirectional promoters (implicated in B/O cancers) have a 
distinct network from unidirectional promoters. The identification of putative binding sites 
provides the first step in the elucidation of higher-order interdependencies among DNA 
repair genes in the cell. We also report preliminary findings on pairs of binding sites that 
represent regulatory modules. Furthermore, we show that there is much overlap among 
promoters of DNA repair genes, and that shared DNA binding motifs can be distributed 
among a collection of alternative promoters, each having distinct combinations of regulatory 
elements. The complex nature of the data can be simplified for visual interpretation using 
visualization techniques such as network modeling and circos diagrams.  
www.intechopen.com
 
Shared Regulatory Motifs in Promoters of Human DNA Repair Genes 83 
 
Fig. 5. Relationships between genes and transcription factors. 
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